Instead, they were originally developed as a temporary solution in response to a 2022 national shortage of their brand-name precursors
PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes GLP1R rs6923761 and 13 other pathway variants that influence how your nervous system responds to GLP-1 activation
This growth was accelerated in 2021 when the FDA approved semaglutide, a Novo Nordisk product under the brand name of Wegovy, for chronic weight management
And as indicated by the list above of upcoming trials, there may be several new indications in the near future
Also known by its research identifier LY3437943 , Retatrutide is a next-generation triple receptor agonist designed to activate the GLP-1, GIP, and glucagon receptors simultaneously
30-53% of new cases are directly linked to obesity